| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Perspective Therapeutics, Inc.
13D/A
CATX · 46489V302
|
7.7% |
9/23/2026
Event 9/21/2026
|
||||
| Lantheus Holdings, Inc. | 7.7% | |||||
| Lantheus Medical Imaging, Inc. | 7.7% | |||||
| Lantheus Alpha Therapy, LLC | 7.7% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Radiopharm Theranostics Limited
13G
Q79455103
|
17.3% |
9/4/2026
Event 7/28/2026
|
||||
| Lantheus Omega, LLC | 17.3% | |||||
| Lantheus Medical Imaging, Inc. | 17.3% | |||||
| Lantheus Holdings, Inc. | 17.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.